Interestingly, the treatment of CGTH-W-1 with FGF2 resulted in the higher expression of PROX1, which indicates mutual regulation of PROX1 and FGF2 signaling generating a regulatory loop in thyroid cancer cells. Here, PROX1 is linked to thyroid gland carcinoma.